Unibrol 125 mg/5ml contains Aminosidine (paromomycin) which is an aminoglycoside antibiotic that has been administered by mouth as sulphate in the treatment of intestinal protozoal infection including amoebiasis, cryptosporidiosis, and giardiasis. It has also been tried parenterally for visceral and topically for cutaneous leishmaniasis. Aminosidine may also be used for the treatment of tapeworm infection, but it is not the treatment of choice. Similarly to Neomycin, Aminosidine has been used in the suppression of intestinal flora both preoperatively and in the management of hepatic encephalopathy. Unibrol syrup: Each 5ml contains 125 mg aminosidine U.S.P (as sulphate). Aminosidine is active against various protozoa including: Leishmania spp; Entamoeba histolytica, and Cryptosporidium spp. In addition, it has an antibacterial spectrum similar to that of neomycin. It is active against many strains of gram-negative bacteria including species of Brucella, Calymmatobacterium, Campylobacter, Citrobacter, Escherichia, Enterobacter, Klebsiella, proteus, Serratia Vibrio and Yersinia. Aminosidine has been reported to be active against Mycobacterium tuberculosis but lacks activity against Pseudomonas aeruginosa.